CClinicalTrials.gg
CompletedNCT00798564Updated Mar 18, 2021

Exercise Induced Asthma and Airway Reactivity in Athletes

An observational study in Respiratory Function Tests, sponsored by Skane University Hospital. Completed. Open to participants aged 16 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-03-18.

Sponsored by Skane University Hospital · Observational

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
300
Ages
16 Years to 25 Years
Sex
All
01

Study summary

The overall aim is to explore pathophysiological factors related to airway hyperresponsiveness to direct and indirect provocation stimuli in athletes with different sport activities, with special focus on epithelial reaction linked to CC16 and to eicosanoid related inflammatory response. The investigators also wish to compare indirect testing done as hyper osmotic challenge with Mannitol compared to a defined sport specific exercise challenge.

Read the detailed description

By non-invasive tools the investigators wish to characterize type of airway reaction to various provocative stimuli in athletes doing two different sort activities, Tennis or swimming. As controls are being used sedentary age-matched controls from the same region, exposed to the same school environment. Thus we wish to:

  • explore the prevalence of positive mannitol reactivity among swimmers and tennis player and how this relates to symptoms, disease history and to a sport specific exercise provocation test.
  • compare the results from sport specific testing with a standardized eucapnic hyperventilation test (EHV)
  • compare the overall reactivity to mannitol or EHV among swimmers and tennis players compared to aged matched controls.
  • explore the role by CC16 in airway reactivity to different provocative stimuli and to see whether there is a difference between different sport activities, different test protocols and between athletes and controls.
  • explore evidence of eicosanoid related inflammatory reaction in athletes and controls in relation to different provocative stimuli

The study population consists of 100 elite swimmers, 100 elite tennis players and 100 non-elite, eged matched controls. In the latter group, 30 are aged matched non-atopic non-asthmatic controls.

02

Conditions studied

  • Respiratory Function Tests

Keywords

  • Exercise
  • Mannitol
03

Who can participate

Ages eligible
16 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

100 elite swimmers 100 elite tennis players 100 aged matched non-atletic subjects, 30 aged-matcked healthy non-atopic controls

Inclusion criteria

  • Subjects aged 16-19 from Skåne.
  • All should approve attendance in the study by signing an informed consent. Igf they are aged under 18, parents should also sign.
  • Three groups are included
  • Elite aspiring swimmers with an average training intensity of at least hours per week the last year.

Exclusion criteria

Exclusion Criteria:

04

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
300 participants (actual)
05

Study locations

No study locations are listed for this record.

06

Registry details

Key details

Study ID
NCT00798564
Lead sponsor
Skane University Hospital
Collaborators
Swedish Heart Lung Foundation
Responsible party
Leif Bjermer (Professor, MD, Skane University Hospital) — Principal investigator
First posted
Nov 26, 2008
Start date
Mar 2008
Primary completion
Jul 2009
Completion
Dec 2009
Last update
Mar 18, 2021

Study contacts

Leif H Bjermer, MD, PhD
principal investigator · Lund University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion